New blood test aims to catch live prostate cancer cells
NCT ID NCT04581109
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new blood test called EPIDROP that looks for live circulating tumor cells in men with metastatic prostate cancer. The test uses a special technique to isolate single cells and measure their activity. Researchers want to see if EPIDROP is as good as or better than the current standard test, CellSearch. The study involves 100 men with metastatic prostate cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EPIDROP blood test
What this could lead to
If successful, this could provide a more accurate and sensitive way to detect circulating tumor cells, helping guide treatment decisions for prostate cancer.
What could go wrong
This is an early-stage diagnostic study with 100 participants, so results may not be definitive or widely applicable. The new test may not prove better than the existing method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Center, Hospital
Nîmes, France
-
University Hospital Center
Montpellier, Occitanie, 34295, France